Table 1 Group characteristics across the analysed subtypes and differences compared to the subtype B.

From: Molecular epidemiology and HIV-1 variant evolution in Poland between 2015 and 2019

 

Subtype A

p

Subtype B

p

Subtype C

p

Subtype D

p

Subtype F1

p

Subtype G

p

CRF01_AE

p

CRF02_AG

p

Other CRFs (n = 14)

and URFs (n = 30)

p

Total non-B

p

n = 229

n = 2163

n = 26

n = 27

n = 2

n = 6

n = 8

n = 13

n = 355

Male, n (%)

184 (80.3)

0.01 *

1872 (86.5)

ref

20 (76.9)

0.15

9 (33.3)

0.001 *

2 (100)

1

3 (50.0)

0.036 *

6 (75.0)

0.30

11 (84.6)

0.69

39 (88.6)

0.69

274 (77.2)

0.001 *

Female, n (%)

45

(19.7)

291

(13.5)

6

(23.1)

18

(66.7)

0

3

(50.0)

2

(25.0)

2

(15.4)

5

(11.4)

81

(22.8)

HIV infection stage at genotyping, n (%)(a)

• non-AIDS

70 (84.3)

0.38

473 (80,3)

ref

5 (83.3)

0.85

2 (50.0)

0.13

1 (50.0)

0.28

2 (100)

0.48

3 (75.0)

0.79

3 (100)

0.39

6 (50.0)

0.0098 *

92 (79.3)

0.81

• AIDS

13 (15.7)

116 (19,7)

1 (16.7)

2 (50.0)

1 (50.0)

0

1 (25.0)

0

6 (50.0)

24 (20.7)

Dominant transmission rout, n (%)

• Intravenous drug use

4 (3,9)

0.26

37 (5.4)

ref

0

0.40

2 (33.3)

0.001 *

0

0.71

0

0.71

0

0.64

0

0.033 *

0

0.28

6 (4,3)

0.0031 *

• Men having sex with men

71 (69,6)

517 (76)

4 (57.1)

0

1 (50.0)

1 (50.0)

3 (60.0)

0

8 (61.5)

88 (63,3)

• Heterosexual

27 (26,5)

125 (18,4)

3 (42.9)

4 (66.7)

1 (50.0)

1 (50.0)

2 (40.0)

2 (100)

5 (38.5)

45 (32,4)

• Vertical

0

1 (0.2)

0

0

0

0

0

0

0

0

Lymphocyte CD4 + T cell

counts at baseline,

median

457

0.006 *

373

ref

581

0.073

301

0.76

308

0.71

399

0.91

651

0.025 *

387

0.77

176

0.10

454

0.014 *

(IQR)

(291—630)

(176—572)

(471—609)

(139—552)

(230—387)

(271—526)

(570—842)

(280—446)

(28—484)

(244—629)

Nadir lymphocyte CD4 + T cell counts, median

451

0.015 *

358

ref

562

0.18

301

0.89

308

0.77

80

0.081

651

0.015 *

387

0.42

140

0.26

444

0.022 *

(IQR)

(282—579)

(174—541)

(423—606)

(301—426)

(230—387)

(60—99)

(570—842)

(280—446)

(42—490)

(249—586)

HIV viral load at baseline, mean log copies/ml

4.7

0.72

4.6

ref

4.4

0.44

4.3

0.36

5.8

0.055

4.2

0.19

4.0

0.096

4.0

0.28

5.5

0.001 *

4.7

0.69

(SD)

(3.8—5.6)

(3.7—5.5)

(3.2—5.6)

(3.1—5.5)

(5.5—6.1)

(3.7—4.7)

(3.1—4.9)

(2.7—5.3)

(4.5—6.5)

(3.6—5.8)

Age at diagnosis, median years

34

0.12

35

ref

37

0.18

40

0.001 *

40

0.92

39

0.19

39

0.21

34

0.88

34

0.24

34

0.21

(IQR)

(29—40)

(29—42)

(31—51)

(39—58)

(32—48)

(35—46)

(34—47)

(30—39)

(29—43)

(30—41)

  1. (a) HIV infection stage available for 705 patients, transmission route for 819 patients, baseline lymphocyte CD4 + T cell count for 846 patients, nadir lymphocyte CD4 + T cell counts for 791 patients, HIV viral load for 1392 patients and age at diagnosis for 2517 patients.
Back to article page